Defunct Company
Total Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
2,477
NCT01587313
A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2012
Completion: May 31, 2012
NCT01588535
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Phase: Phase 2
Start: May 31, 2012
Completion: Aug 31, 2012
NCT01876719
AR08 for Treatment of ADHD in Children
Start: Jun 30, 2013
Completion: Feb 28, 2015
NCT01986062
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Phase: Phase 4
Start: Dec 31, 2013
Completion: May 31, 2014
NCT02027155
Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09
Completion: Apr 30, 2014
NCT02044341
Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media
Phase: Phase 3
Completion: Mar 31, 2014
NCT02074007
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
Completion: Jun 30, 2014
NCT02049164
Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)
Start: Jan 31, 2014
NCT02723669
Relative Bioavailability of AR10 Compared to Reference Product
Start: Apr 30, 2014
NCT02235909
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
Start: Mar 30, 2015
Completion: Nov 11, 2019
NCT02252536
HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder
Role: Collaborator
Start: Jun 30, 2015
Completion: Mar 31, 2017
NCT02522208
Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets
Start: Sep 30, 2015
Completion: Apr 30, 2016
NCT02684838
Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Phase: N/A
Start: Apr 26, 2016
Completion: Oct 31, 2025
NCT03659929
Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
Start: Sep 18, 2018
Completion: Apr 12, 2019
NCT04222062
A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
Start: Nov 6, 2020
Completion: Dec 31, 2028
NCT06097676
An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users
Start: Sep 28, 2021
Completion: Jun 30, 2022
NCT06247488
Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users
Start: Jan 31, 2022
Completion: Apr 25, 2023